Riskpilot← Back to searchSign inGet full accessNORSELAB IMPACT AS
ASActiveOrg 918392033Nedre Slottsgate 5, 0157 OsloBusiness and other management consultancy activities · NACE 7020Est. 20175 employees
Revenue 2024
NOK 6,7M
-5% vs 2023
EBITDA margin
-132.9%
+32% vs 2023
Equity ratio
14.6%
Financial strength
Net profit 2024
NOK -8,9M
+33% vs 2023
| Revenue | NOK 6,7M | -5% |
| EBITDA | NOK -8,9M | +32% |
| Net profit | NOK -8,9M | +33% |
| Total assets | NOK 15M | +298% |
| Equity | NOK 2,2M | +452% |
| Employees | 5 | — |
Legal name
NORSELAB IMPACT AS
Org number
918392033
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
18. januar 2017
Share capital
NOK 2 307 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Investering i aksjer og andre eierandeler i andre selskaper og foretak, samt all annen virksomhet som hermed står i forbindelse.
Address
Nedre Slottsgate 5, 0157 Oslo
Phone
+4741213911
Email
hello@norselab.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 619 | 4 | 4 502 | 7 064 | 6 687 |
| Staff expenses | −2 240 | −174 | −11 610 | −12 710 | −0 |
| EBITDA | 2 144 | −394 | −11 061 | −13 024 | −8 890 |
| Depreciation & amort. | −65 | −3 | −83 | −163 | −0 |
| EBIT | 2 079 | −398 | −11 144 | −13 187 | −8 890 |
| Net financials | 66 045 | −1 | −25 | −73 | −6 |
| Profit before tax | 68 124 | −398 | −11 169 | −13 260 | −8 896 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 68 124 | −398 | −11 169 | −13 260 | −8 896 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 60 183 | 3 491 | 7 096 | 3 761 | 14 960 |
| Equity | 59 947 | 3 008 | 4 839 | −621 | 2 183 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 236 | 482 | 2 257 | 4 382 | 12 777 |
| Total debt | 236 | 482 | 2 257 | 4 382 | 12 777 |
EBITDA margin
-132.9%
This company
15.8%
Market median
-941% vs market
20202024
Equity ratio
14.6%
This company
38.2%
Market median
-62% vs market
20202024
Return on equity
-407.5%
This company
18.4%
Market median
-2315% vs market
20202024
Net profit margin
-133.0%
This company
8.1%
Market median
-1742% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
5.85×
This company
0.62×
Market median
-844% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MG Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norselab Group As
NORSELAB IMPACT AS Board members of NORSELAB IMPACT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Grimstad De Perlinghi | Chief Executive Officer | 0 companies |
| Erik Skaar Syvertsen | Board of Directors | 0 companies |
| Sturla Hassel | Board of Directors | 0 companies |
| Yngve Tvedt | Chairman | 0 companies |